Regulation of class IIa HDAC activities: It is not only matter of subcellular localization

Epigenomics

Volumn 8, Issue 2, 2016, Pages 251-269

  Di Giorgio, Eros ^a   Brancolini, Claudio ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

AMPK; FOXO; HDAC4; HDAC5; HDAC7; HDAC9; LKB; MEF2; PKD; SIK

Indexed keywords

ADENYLATE KINASE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 7; HISTONE DEACETYLASE 9; MESSENGER RNA; MICRORNA; MICRORNA 155; MICRORNA 200A; MICRORNA 22; MICRORNA 29A; MICRORNA 9; MULTIPROTEIN COMPLEX; PHOSPHATASE; PROTEIN 14 3 3; PROTEIN KINASE LKB1; PROTEIN SERINE THREONINE KINASE; CALCIUM; PROTEIN KINASE;

AMINO TERMINAL SEQUENCE; CELL FUNCTION; CELL NUCLEUS; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENOMICS; HUMAN; MOLECULAR MECHANICS; NONHUMAN; NUCLEAR IMPORT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; REVIEW; RNA STABILITY; TRANSCRIPTION REGULATION; ANIMAL; CLASSIFICATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GENOME; INTRACELLULAR SPACE; METABOLISM; NEOPLASM; PROTEIN TRANSPORT; RNA INTERFERENCE;

ANIMALS; CALCIUM; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENOME; HISTONE DEACETYLASES; HUMANS; INTRACELLULAR SPACE; MICRORNAS; NEOPLASMS; PROTEIN KINASES; PROTEIN TRANSPORT; PROTEOLYSIS; RNA INTERFERENCE; RNA STABILITY; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 84959337712     PISSN: 17501911     EISSN: 1750192X     Source Type: Journal    
DOI: 10.2217/epi.15.106     Document Type: Review

References (146)

1. Choudhary C, Kumar C, Gnad F et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 325(5942), 834-840 (2009).
2. Yang X-J, Seto E. The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men. Nat. Rev. Mol. Cell Biol. 9(3), 206-218 (2008).
3. Clocchiatti A, Di Giorgio E, Demarchi F, Brancolini C. Beside the MEF2 axis: unconventional functions of HDAC4. Cell. Signal. 25(1), 269-276 (2013).
4. Clocchiatti A, Florean C, Brancolini C. Class IIa HDACs: from important roles in differentiation to possible implications in tumourigenesis. J. Cell. Mol. Med. 15(9), 1833-1846 (2011).
5. Parra M. Class IIa HDACs-new insights into their functions in physiology and pathology. FEBS J. 282(9), 1736-44 (2015).
6. Thierry-Mieg D, Thierry-Mieg J. AceView: A comprehensive cDNA-supported gene and transcripts annotation. Genome Biol. 7(Suppl. 1), S12.1-S14.1 (2006).
7. Zhou B, Margariti A, Zeng L et al. Splicing of histone deacetylase 7 modulates smooth muscle cell proliferation and neointima formation through nuclear β-catenin translocation. Arterioscler. Thromb. Vasc. Biol. 31(11), 2676-2684 (2011).
8. Margariti A, Xiao Q, Zampetaki A et al. Splicing of HDAC7 modulates the SRF-myocardin complex during stem-cell differentiation towards smooth muscle cells. J. Cell Sci. 122(Pt 4), 460-470 (2009).
9. Petrie K, Guidez F, Howell L et al. The histone deacetylase 9 gene encodes multiple protein isoforms. J. Biol. Chem. 278(18), 16059-16072 (2003).
10. Zhang CL, McKinsey TA, Olson EN. The transcriptional corepressor MITR is a signal-responsive inhibitor of myogenesis. Proc. Natl Acad. Sci. USA 98(13), 7354-7359 (2001).
11. Kirsh O, Seeler JS, Pichler A et al. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 21(11), 2682-2691 (2002).
12. Liu F, Pore N, Kim M et al. Regulation of histone deacetylase 4 expression by the SP family of transcription factors. Mol. Biol. Cell. 17(2), 585-597 (2006).
13. Sleiman SF, Langley BC, Basso M et al. Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration. J. Neurosci. 31(18), 6858-6870 (2011).
14. Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C. Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res. 35(2), 645-51 (2015).
15. Zhang L, Jin M, Margariti A et al. Sp1-dependent activation of HDAC7 is required for platelet-derived growth factor-BBinduced smooth muscle cell differentiation from stem cells. J. Biol. Chem. 285(49), 38463-72 (2010).
16. Zhou B, Margariti A, Zeng L et al. Splicing of histone deacetylase 7 modulates smooth muscle cell proliferation and neointima formation through nuclear-catenin translocation. Arterioscler. Thromb. Vasc. Biol. 31(11), 2676-2684 (2011).
17. Tang H, Macpherson P, Marvin M et al. A histone deacetylase 4/myogenin positive feedback loop coordinates denervation-dependent gene induction and suppression. Mol. Biol. Cell. 20(4), 1120-1131 (2009).
18. Vega RB, Matsuda K, Oh J et al. Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119, 555-566 (2004).
19. Barneda-Zahonero B, Román-González L, Collazo O et al. HDAC7 Is a repressor of myeloid genes whose downregulation is required for transdifferentiation of pre-B cells into macrophages. PLoS Genet. 9(5), e1003503 (2013).
20. Addis RC, Prasad MK, Yochem RL et al. OCT3/4 regulates transcription of histone deacetylase 4 (Hdac4) in mouse embryonic stem cells. J. Cell. Biochem. 111, 391-401 (2010).
21. Haberland M, Arnold MA, McAnally J, Phan D, Kim Y, Olson EN. Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation. Mol. Cell. Biol. 27(2), 518-525 (2007).
22. Mihaylova MM, Vasquez DS, Ravnskjaer K et al. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145, 607-621 (2011).
23. Clocchiatti A, Di Giorgio E, Ingrao S, Meyer-Almes F-J, Tripodo C, Brancolini C. Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER+ breast tumors. FASEB J. 27, 942-954 (2013).
24. Clocchiatti A, Di Giorgio E, Viviani G et al. The MEF2-HDAC axis controls proliferation of mammary epithelial cells and acini formation in vitro. J. Cell Sci. 128(21), 3961-3976 (2015).
25. Rosenbloom KR, Dreszer TR, Long JC et al. ENCODE whole-genome data in the UCSC genome browser: update 2012. Nucleic Acids Res. 40, D912-D917 (2012).
26. Di Giorgio E, Clocchiatti A, Piccinin S et al. MEF2 is a converging hub for histone deacetylase 4 and phosphatidylinositol 3-kinase/Akt-induced transformation. Mol. Cell. Biol. 33, 4473-91 (2013).
27. Zhu J, Shimizu E, Zhang X, Partridge NC, Qin L. EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix. J. Cell. Biochem. 112(7), 1749-1760 (2011).
28. Vella P, Barozzi I, Cuomo A, Bonaldi T, Pasini D. Yin Yang 1 extends the Myc-related transcription factors network in embryonic stem cells. Nucleic Acids Res. 40(8), 3403-3418 (2012).
29. Chen J-F, Mandel EM, Thomson JM et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet. 38, 228-233 (2006).
30. Liu N, Williams AH, Kim Y et al. An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc. Natl Acad. Sci. USA 104, 20844-20849 (2007).
31. Ikeda S, He A, Kong SW et al. MicroRNA-1 negatively regulates expression of the hypertrophy-associated calmodulin and Mef2a genes. Mol. Cell. Biol. 29, 2193-2204 (2009).
32. Davila JL, Goff LA, Ricupero CL et al. A positive feedback mechanism that regulates expression of miR-9 during neurogenesis. PLoS ONE 9(4), e94348 (2014).
33. Sun Y, Ge Y, Drnevich J, Zhao Y, Band M, Chen J. Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. J. Cell Biol. 189, 1157-1169 (2010).
34. Li P, Wei X, Guan Y, Chen Q, Zhao T, Sun C, Wei L. MicroRNA-1 regulates chondrocyte phenotype by repressing histone deacetylase 4 during growth plate development. FASEB J. 28( 9), 3930-3941 (2014).
35. Guan Y-J, Yang X, Wei L, Chen Q. MiR-365: A mechanosensitive microRNA stimulates chondrocyte differentiation through targeting histone deacetylase 4. FASEB J. 25, 4457-4466 (2011).
36. Li Z, Hassan MQ, Jafferji M et al. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J. Biol. Chem. 284(23), 15676-15684 (2009).
37. Winbanks CE, Wang B, Beyer C et al. TGF-b regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J. Biol. Chem. 286, 13805-13814 (2011).
38. Williams AH, Valdez G, Moresi V et al. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326(5959), 1549-1554 (2009).
39. Valsecchi V, Boido M, De Amicis E, Piras A, Vercelli A. Expression of muscle-specific MiRNA 206 in the progression of disease in a murine SMA model. PLoS ONE 10(6), e0128560 (2015).
40. Ren J, Huang HJ, Gong Y et al. MicroRNA-206 suppresses gastric cancer cell growth and metastasis. Cell Biosci. 5(4), 26 (2014).
41. Singh A, Happel C, Manna SK et al. Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. J. Clin. Invest. 123(7), 2921-2934 (2013).
42. Ago T, Liu T, Zhai P et al. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell 133, 978-993 (2008).
43. Gagan J, Dey BK, Layer R, Yan Z, Dutta A. Notch3 and Mef2c proteins are mutually antagonistic via Mkp1 protein and miR-1/206 microRNAs in differentiating myoblasts. J. Biol. Chem. 287(48), 40360-40370 (2012).
44. Gruber AJ, Zavolan M. Modulation of epigenetic regulators and cell fate decisions by miRNAs. Epigenomics 5(6), 671-83 (2013).
45. Mielcarek M, Landles C, Weiss A et al. HDAC4 reduction: A novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration. PLoS Biol. 11(11), e1001717 (2013).
46. Mielcarek M, Toczek M, Smeets CJ et al. HDAC4-myogenin axis as an important marker of HD-related skeletal muscle atrophy. PLoS Genet. 11(3), e1005021 (2015).
47. Jovicic A, Zaldivar Jolissaint JF, Moser R, Silva Santos M de F, Luthi-Carter R. MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific huntington's disease-related mechanisms. PLoS ONE 8(1), e54222 (2013).
48. Huang ZP, Chen J, Seok HY et al. MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ. Res. 112(9), 1234-1243 (2013).
49. Lu W, You R, Yuan X et al. The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote TH17 celldependent emphysema. Nat. Immunol. 16(11), 1185-1194 (2015).
50. Han K, Gennarino VA, Lee Y et al. Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p. Genes Dev. 27(5), 485-490 (2013).
51. Li H, Xie H, Liu W et al. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J. Clin. Invest. 119(12), 3666-3677 (2009).
52. Fischer S, Paul AJ, Wagner A et al. miR-2861 as novel HDAC5 inhibitor in CHO cells enhances productivity while maintaining product quality. Biotechnol Bioeng. 112(10), 2142-2153 (2015).
53. Li CJ, Cheng P, Liang MK et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J. Clin. Invest. 125(4), 1509-1522 (2015).
54. Nasser MW, Datta J, Nuovo G et al. Down-regulation of micro-RNA-1 (miR-1) in lung cancer: suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J. Biol. Chem. 283, 33394-33405 (2008).
55. Datta J, Kutay H, Nasser MW et al. Methylation mediated silencing of microRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res. 68, 5049-5058 (2008).
56. Duan Z, Choy E, Nielsen GP et al. Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression. J. Orthop. Res. 6, 746-752 (2010).
57. Zhang J, Yang Y, Yang T et al. microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br. J. Cancer 103, 1215-1220 (2010).
58. Song B, Wang Y, Xi Y et al. Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 28(46), 4065-4074 (2009).
59. Roccaro AM, Sacco A, Jia X et al. microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia. Blood 116(9), 1506-1514 (2010).
60. Wilson AJ, Byun D-S, Nasser S et al. HDAC4 promotes growth of colon cancer cells via repression of p21. Mol. Biol. Cell 19, 4062-4075 (2008).
61. Mottet D, Pirotte S, Lamour V et al. HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism. Oncogene 28, 243-256 (2009).
62. Yuan J hang, Yang F, Chen B feng et al. The histone deacetylase 4/SP1/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma. Hepatology 54(6), 2025-2035 (2011).
63. Nishida N, Mimori K, Fabbri M et al. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin. Cancer Res. 17(9), 2725-2733 (2011).
64. Sandhu SK, Volinia S, Costinean S et al. miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model. Proc. Natl Acad. Sci. USA 109(49), 20047-20052 (2012).
65. Kai Y, Peng W, Ling W, Jiebing H, Zhuan B. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells. Biochem. Biophys. Res. Commun. 448, 308-314 (2014).
66. Wu MY, Fu J, Xiao X, Wu J, Wu RC. MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancer. Cancer Lett. 354(2), 311-319 (2014).
67. Paroni G, Mizzau M, Henderson C, Del Sal G, Schneider C, Brancolini C. Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis. Mol. Biol. Cell 15, 2804-2818 (2004).
68. Scott FL, Fuchs GJ, Boyd SE et al. Caspase-8 cleaves histone deacetylase 7 and abolishes its transcription repressor function. J. Biol. Chem. 283, 19499-19510 (2008).
69. Liu F, Dowling M, Yang XJ, Kao GD. Caspase-mediated specific cleavage of human histone deacetylase 4. J. Biol. Chem. 279, 34537-34546 (2004).
70. Backs J, Worst BC, Lehmann LH et al. Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. J. Cell Biol. 195, 403-415 (2011).
71. Li X, Song S, Liu Y, Ko SH, Kao HY. Phosphorylation of the histone deacetylase 7 modulates its stability and association with 14-3-3 proteins. J. Biol. Chem. 279(33), 34201-34208 (2004).
72. Bradley EW, Carpio LR, Olson EN, Westendorf JJ. Histone deacetylase 7 (Hdac7) suppresses chondrocyte proliferation and β-catenin activity during endochondral ossification. J. Biol. Chem. 290, 118-126 (2015).
73. Arnold MA, Kim Y, Czubryt MP et al. MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev. Cell. 12, 377-389 (2007).
74. Potthoff MJ, Wu H, Arnold MA et al. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J. Clin. Invest. 117, 2459-2467 (2007).
75. Cernotta N, Clocchiatti A, Florean C, Brancolini C. Ubiquitin-dependent degradation of HDAC4, a new regulator of random cell motility. Mol. Biol. Cell. 22, 278-289 (2011).
76. Shimizu E, Nakatani T, He Z, Partridge NC. Parathyroid hormone regulates histone deacetylase (HDAC) 4 through protein kinase A-mediated phosphorylation and dephosphorylation in osteoblastic cells. J. Biol. Chem. 289, 21340-50 (2014).
77. Obri A, Makinistoglu MP, Zhang H, Karsenty G. HDAC4 integrates PTH and sympathetic signaling in osteoblasts. J. Cell Biol. 205(6), 771-780 (2014).
78. Guo L, Han A, Bates DL, Cao J, Chen L. Crystal structure of a conserved N-terminal domain of histone deacetylase 4 reveals functional insights into glutamine-rich domains. Proc. Natl Acad. Sci. USA 104, 4297-4302 (2007).
79. Grégoire S, Tremblay AM, Xiao L et al. Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation. J. Biol. Chem. 281, 4423-4433 (2006).
80. Gao C, Ho C-C, Reineke E et al. Histone deacetylase 7 promotes PML sumoylation and is essential for PML nuclear body formation. Mol. Cell. Biol. 28, 5658-5667 (2008).
81. Lee JH, Park SM, Kim OS et al. Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes. Mol. Cell 35, 806-817 (2009).
82. Grozinger CM, Schreiber SL. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc. Natl Acad. Sci. USA 97, 7835-7840 (2000).
83. Nishino TG, Miyazaki M, Hoshino H, Miwa Y, Horinouchi S, Yoshida M. 14-3-3 regulates the nuclear import of class IIa histone deacetylases. Biochem. Biophys. Res. Commun. 377, 852-856 (2008).
84. Paroni G, Cernotta N, Dello Russo C et al. PP2A regulates HDAC4 nuclear import. Mol. Biol. Cell. 19, 655-667 (2008).
85. Fischle W, Dequiedt F, Hendzel MJ et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/NCoR. Mol. Cell. 9, 45-57 (2002).
86. McKinsey TA, Zhang CL, Lu J, Olson EN. Signaldependent nuclear export of a histone deacetylase regulates muscle differentiation. Nature 408, 106-111 (2000).
87. Backs J, Olson EN. Control of cardiac growth by histone acetylation/deacetylation. Circ. Res. 98, 15-24 (2006).
88. Martin M, Potente M, Janssens V et al. Protein phosphatase 2A controls the activity of histone deacetylase 7 during T cell apoptosis and angiogenesis. Proc. Natl Acad. Sci. USA 105(12), 4727-4732 (2008).
89. Kozhemyakina E, Cohen T, Yao T-P, Lassar AB. Parathyroid hormone-related peptide represses chondrocyte hypertrophy through a protein phosphatase 2A/histone deacetylase 4/MEF2 pathway. Mol. Cell. Biol. 29, 5751-5762 (2009).
90. Martin M, Kettmann R, Dequiedt F. Class IIa histone deacetylases: regulating the regulators. Oncogene 26, 5450-5467 (2007).
91. Wang Z, Qin G, Zhao TC. HDAC4: mechanism of regulation and biological functions. Epigenomics 6(1), 139-50 (2014).
92. Li C, Cai X, Sun H et al. The δA isoform of calmodulin kinase II mediates pathological cardiac hypertrophy by interfering with the HDAC4-MEF2 signaling pathway. Biochem. Biophys. Res. Commun. 409, 125-130 (2011).
93. Paroni G, Fontanini A, Cernotta N et al. Dephosphorylation and caspase processing generate distinct nuclear pools of histone deacetylase 4. Mol. Cell. Biol. 27, 6718-6732 (2007).
94. Walkinshaw DR, Weist R, Kim GW et al. The tumor suppressor kinase LKB1 activates the downstream kinases SIK2 and SIK3 to stimulate nuclear export of class IIa histone deacetylases. J. Biol. Chem. 288, 9345-9362 (2013).
95. Backs J, Song K, Bezprozvannaya S, Chang S, Olson EN. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. 116(7), 1853-1864 (2006).
96. Backs J, Backs T, Bezprozvannaya S, McKinsey TA, Olson EN. Histone deacetylase 5 acquires calcium/calmodulindependent kinase II responsiveness by oligomerization with histone deacetylase 4. Mol. Cell. Biol. 28, 3437-3445 (2008).
97. Bolger TA, Yao T-P. Intracellular trafficking of histone deacetylase 4 regulates neuronal cell death. J. Neurosci. 25, 9544-9553 (2005).
98. Shalizi A, Gaudillière B, Yuan Z et al. A calciumregulated MEF2 sumoylation switch controls postsynaptic differentiation. Science 311, 1012-1017 (2006).
99. Métrich M, Berthouze M, Morel E, Crozatier B, Gomez AM, Lezoualc'h F. Role of the cAMP-binding protein Epac in cardiovascular physiology and pathophysiology. Pflugers Arch. Eur. J. Physiol. 459, 535-546 (2010).
100. Métrich M, Laurent AC, Breckler M et al. Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway. Cell. Signal. 22, 1459-1468 (2010).
101. Dequiedt F, Van Lint J, Lecomte E et al. Phosphorylation of histone deacetylase 7 by protein kinase D mediates T cell receptor-induced Nur77 expression and apoptosis. J. Exp. Med. 201, 793-804 (2005).
102. Matthews SA, Liu P, Spitaler M et al. Essential role for protein kinase D family kinases in the regulation of class II histone deacetylases in B lymphocytes. Mol Cell Biol. 26, 1569-1577 (2006).
103. Wilker PR, Kohyama M, Sandau MM et al. Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation. Nat. Immunol. 9, 603-612 (2008).
104. Parra M, Kasler H, McKinsey TA, Olson EN, Verdin E. Protein kinase D1 phosphorylates HDAC7 and induces its nuclear export after T-cell receptor activation. J. Biol. Chem. 280, 13762-13770 (2005).
105. Sin YY, Baillie GS. Protein kinase D in the hypertrophy pathway. Biochem. Soc. Trans. 40(1), 287-9 (2012).
106. Xu X, Ha CH, Wong C et al. Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy. Arterioscler. Thromb. Vasc. Biol. 27, 2355-2362 (2007).
107. Sinnett-Smith J, Ni Y, Wang J, Ming M, Young SH, Rozengurt E. Protein kinase D1 mediates class IIa histone deacetylase phosphorylation and nuclear extrusion in intestinal epithelial cells: role in mitogenic signaling. Am. J. Physiol. Cell Physiol. 306(10), C961-C971 (2014).
108. Kim M-S, Fielitz J, McAnally J et al. Protein kinase D1 stimulates MEF2 activity in skeletal muscle and enhances muscle performance. Mol. Cell. Biol. 28, 3600-3609 (2008).
109. Hardie DG. AMP-activated protein kinase-an energy sensor that regulates all aspects of cell function. Genes Dev. 25(18), 1895-1908 (2011).
110. Dequiedt F, Martin M, Von Blume J et al. New role for hPar-1 kinases EMK and C-TAK1 in regulating localization and activity of class IIa histone deacetylases. Mol. Cell. Biol. 26, 7086-7102 (2006).
111. Bayraktar J, Zygmunt D, Carthew RW. Par-1 kinase establishes cell polarity and functions in Notch signaling in the Drosophila embryo. J. Cell Sci. 119, 711-721 (2006).
112. Guo S, Kemphues KJ. par-1, a gene required for establishing polarity in C. elegans embryos, encodes a putative Ser/Thr kinase that is asymmetrically distributed. Cell 81, 611-620 (1995).
113. Chen S, Yin C, Lao T et al. AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1α and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol. Cell Cycle 14(15), 2520-36 (2015).
114. Zhao J-X, Yue W-F, Zhu M-J, Du M. AMP-activated protein kinase regulates beta-catenin transcription via histone deacetylase 5. J. Biol. Chem. 286(18), 16426-16434 (2011).
115. McGee SL, Fairlie E, Garnham AP, Hargreaves M. Exercise-induced histone modifications in human skeletal muscle. J. Physiol. 587(Pt 24), 5951-5958 (2009).
116. McGee SL, van Denderen BJW, Howlett KF et al. AMPactivated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5. Diabetes. 57, 860-867 (2008).
117. McGee SL, Swinton C, Morrison S et al. Compensatory regulation of HDAC5 in muscle maintains metabolic adaptive responses and metabolism in response to energetic stress. FASEB J. 28(8), 3384-3395 (2014).
118. Katoh Y, Takemori H, Horike N et al. Salt-inducible kinase (SIK) isoforms: their involvement in steroidogenesis and adipogenesis. Mol. Cell. Endocrinol. 217(1-2), 109-112 (2004).
119. Takemori H, Katoh Hashimoto Y, Nakae J, Olson EN, Okamoto M. Inactivation of HDAC5 by SIK1 in AICARtreated C2C12 myoblasts. Endocr. J. 56(1), 121-130 (2009).
120. Dietrich JB, Takemori H, Grosch-Dirrig S, Bertorello A, Zwiller J. Cocaine induces the expression of MEF2C transcription factor in rat striatum through activation of SIK1 and phosphorylation of the histone deacetylase HDAC5. Synapse 66(1), 61-70 (2012).
121. Finsterwald C, Carrard A, Martin JL. Role of salt-inducible kinase 1 in the activation of MEF2-dependent transcription by BDNF. PLoS ONE 8(1), e54545 (2013).
122. Calnan DR, Brunet A. The FoxO code. Oncogene 27, 2276-2288 (2008).
123. Wang B, Moya N, Niessen S et al. A hormone-dependent module regulating energy balance. Cell 145, 596-606 (2011).
124. Henriksson E, Säll J, Gormand A et al. SIK2 regulates CRTCs, HDAC4 and glucose uptake in adipocytes. J. Cell Sci. 128, 472-486 (2015).
125. Luan B, Goodarzi MO, Phillips NG et al. Leptin-mediated increases in catecholamine signaling reduce adipose tissue inflammation via activation of macrophage HDAC4. Cell Metab. 19(6), 1058-1065 (2014).
126. Abu-Farha M, Tiss A, Abubaker J et al. Proteomics analysis of human obesity reveals the epigenetic factor HDAC4 as a potential target for obesity. PLoS ONE 8(9), e75342 (2013).
127. Choi S, Lim DS, Chung J. Feeding and fasting signals converge on the LKB1-SIK3 pathway to regulate lipid metabolism in drosophila. PLoS Genet. 11(5), e1005263 (2015).
128. Berdeaux R, Goebel N, Banaszynski L et al. SIK1 is a class II HDAC kinase that promotes survival of skeletal myocytes. Nat. Med. 13, 597-603 (2007).
129. Stewart R, Akhmedov D, Robb C, Leiter C, Berdeaux R. Regulation of SIK1 abundance and stability is critical for myogenesis. Proc. Natl Acad. Sci. USA 110(1), 117-122 (2013).
130. van der Linden AM, Nolan KM, Sengupta P. KIN-29 SIK regulates chemoreceptor gene expression via an MEF2 transcription factor and a class II HDAC. EMBO J. 26, 358-370 (2007).
131. Li J, Jiang D. The role of epigenomics in the neurodegeneration of ataxia-telangiectasia. Epigenomics 7(2), 137-141 (2015).
132. Li J, Chen J, Ricupero CL et al. Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. Nat. Med. 18, 783-790 (2012).
133. Parra M, Mahmoudi T, Verdin E. Myosin phosphatase dephosphorylates HDAC7, controls its nucleocytoplasmic shuttling, and inhibits apoptosis in thymocytes. Genes Dev. 21, 638-643 (2007).
134. Chang S, McKinsey TA, Zhang CL, Richardson JA, Hill JAOE. Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol. Cell. Biol. 24, 8467-8476 (2004).
135. Perry RLS, Yang C, Soora N et al. Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1alpha represses MEF2-dependent gene expression. Mol. Cell. Biol. 29, 3355-3366 (2009).
136. Greco TM, Yu F, Guise AJ, Cristea IM. Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. Mol. Cell. Proteomics. 10(2), M110.004317 (2011).
137. Deng X, Ewton DZ, Mercer SE, Friedman E. Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation. J. Biol. Chem. 280, 4894-4905 (2005).
138. Ha CH, Kim JY, Zhao J et al. PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy. Proc. Natl Acad. Sci. USA 107, 15467-15472 (2010).
139. Taniguchi M, Carreira MB, Smith LN, Zirlin BC, Neve RL, Cowan CW. Histone deacetylase 5 limits cocaine reward through camp-induced nuclear import. Neuron 73, 108-120 (2012).
140. Ago T, Liu T, Zhai P et al. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell 133, 978-993 (2008).
141. Di Giorgio E, Gagliostro E, Brancolini C. Selective class IIa HDAC inhibitors: myth or reality. Cell. Mol. Life Sci. 72, 73-86 (2015).
142. Hudson GM, Watson PJ, Fairall L, Jamieson AG, Schwabe JW. Insights into the recruitment of class IIa histone deacetylases (HDACs) to the SMRT/NCoR transcriptional repression complex. J. Biol. Chem. 290, 18237-18244 (2015).
143. Oka SI, Ago T, Kitazono T, Zablocki D, Sadoshima J. The role of redox modulation of class II histone deacetylases in mediating pathological cardiac hypertrophy. J. Mol. Med. 87, 785-791 (2009).
144. Haworth RS, Stathopoulou K, Candasamy AJ, Avkiran M. Neurohormonal regulation of cardiac histone deacetylase 5 nuclear localization by phosphorylation-dependent and phosphorylation-independent mechanisms. Circ. Res. 110(12), 1585-1595 (2012).
145. Du M, Perry RLS, Nowacki NB et al. Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D. Mol. Cell. Biol. 28, 2952-2970 (2008).
146. Guise AJ, Greco TM, Zhang IY, Yu F, Cristea IM. Aurora B-dependent regulation of class IIa histone deacetylases by mitotic nuclear localization signal phosphorylation. Mol. Cell. Proteomics 11, 1220-1229 (2012).